| ADR Ontology |
| ADR Term |
Androgens |
| ADR ID |
BADD_A05963 |
| ADR Hierarchy |
|
| Description |
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. [MeSH] |
| MedDRA Code |
10061633 |
| MeSH ID |
D000728
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Androgens NOS | Androgens | Androgenic Compounds | Compounds, Androgenic | Androgen Receptor Agonists | Agonists, Androgen Receptor | Receptor Agonists, Androgen | Androgenic Agents | Agents, Androgenic | Androgen Effect | Effect, Androgen | Androgen Effects | Effects, Androgen |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01585 | Norethindrone | - | - |
| The 1th Page 1
Total 1 Pages
|
|
